Mesa Laboratories Inc
MLAB80.470USD
-0.200-0.25%
Fechamento 12/26, 16:00（ET）Cotações atrasadas em 15 min
443.45MValor de mercado
PerdaP/L TTM
Mais detalhes de Mesa Laboratories Inc Empresa
Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.
Informações de Mesa Laboratories Inc
Código da empresaMLAB
Nome da EmpresaMesa Laboratories Inc
Data de listagemFeb 29, 1984
CEOOwens (Gary M)
Número de funcionários730
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 29
Endereço12100 W 6th Ave
CidadeLAKEWOOD
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal80228
Telefone13039878000
Sitehttps://mesalabs.com
Código da empresaMLAB
Data de listagemFeb 29, 1984
CEOOwens (Gary M)
Executivos da empresa Mesa Laboratories Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Gary M. Owens
Mr. Gary M. Owens
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
148.26K
+8.45%
Dr. John James Sullivan, Ph.D.
Dr. John James Sullivan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
70.06K
-2.78%
Mr. John V. Sakys
Mr. John V. Sakys
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
41.70K
+31.03%
Mr. Brian Archbold
Mr. Brian Archbold
Senior Vice President - Continuous Improvement
Senior Vice President - Continuous Improvement
--
--
Mr. Shiraz S. Ladiwala
Mr. Shiraz S. Ladiwala
Lead Independent Director
Lead Independent Director
--
--
Mr. Mark Christophe Capone
Mr. Mark Christophe Capone
Independent Director
Independent Director
--
--
Ms. Jennifer S. Alltoft
Ms. Jennifer S. Alltoft
Independent Director
Independent Director
--
--
Mr. R. Tony Tripeny
Mr. R. Tony Tripeny
Independent Director
Independent Director
--
--
Ms. Shannon M. Hall
Ms. Shannon M. Hall
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Gary M. Owens
Mr. Gary M. Owens
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
148.26K
+8.45%
Dr. John James Sullivan, Ph.D.
Dr. John James Sullivan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
70.06K
-2.78%
Mr. John V. Sakys
Mr. John V. Sakys
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
41.70K
+31.03%
Mr. Brian Archbold
Mr. Brian Archbold
Senior Vice President - Continuous Improvement
Senior Vice President - Continuous Improvement
--
--
Mr. Shiraz S. Ladiwala
Mr. Shiraz S. Ladiwala
Lead Independent Director
Lead Independent Director
--
--
Mr. Mark Christophe Capone
Mr. Mark Christophe Capone
Independent Director
Independent Director
--
--
Detalhamento da receita
Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Discrete Revenues- Consumables
35.77M
60.08%
Discrete Revenues- Hardware and Software
12.57M
21.11%
Contracted Revenues- Services
7.90M
13.26%
Discrete Revenues- Services
3.31M
5.55%
Por RegiãoUSD
Nome
Receita
Proporção
United States
27.65M
46.43%
Other
26.47M
44.45%
China
5.43M
9.12%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Discrete Revenues- Consumables
35.77M
60.08%
Discrete Revenues- Hardware and Software
12.57M
21.11%
Contracted Revenues- Services
7.90M
13.26%
Discrete Revenues- Services
3.31M
5.55%
Distribuição de ações
Atualizado em: dom, 16 de nov
Atualizado em: dom, 16 de nov
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Conestoga Capital Advisors, LLC
7.72%
BlackRock Institutional Trust Company, N.A.
5.93%
The Vanguard Group, Inc.
5.83%
Ranger Investment Management, L.P.
3.80%
Geneva Capital Management LLC
3.47%
Outro
73.26%
Investidores
Investidores
Proporção
Conestoga Capital Advisors, LLC
7.72%
BlackRock Institutional Trust Company, N.A.
5.93%
The Vanguard Group, Inc.
5.83%
Ranger Investment Management, L.P.
3.80%
Geneva Capital Management LLC
3.47%
Outro
73.26%
Tipos de investidores
Investidores
Proporção
Investment Advisor
37.82%
Investment Advisor/Hedge Fund
35.41%
Hedge Fund
13.57%
Individual Investor
5.44%
Research Firm
4.14%
Bank and Trust
0.88%
Pension Fund
0.84%
Sovereign Wealth Fund
0.06%
Insurance Company
0.03%
Outro
1.82%
Participação acionária institucional
Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
387
5.12M
92.75%
-722.23K
2025Q2
399
5.60M
101.85%
-541.53K
2025Q1
415
5.83M
106.86%
-307.02K
2024Q4
405
5.76M
105.94%
-86.00K
2024Q3
413
5.30M
97.90%
-538.92K
2024Q2
412
5.31M
98.26%
-376.30K
2024Q1
404
5.28M
97.81%
-366.78K
2023Q4
400
5.27M
97.82%
-295.14K
2023Q3
392
5.33M
99.02%
-178.63K
2023Q2
390
5.31M
98.92%
-355.72K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Conestoga Capital Advisors, LLC
566.15K
10.29%
-5.21K
-0.91%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
708.66K
12.88%
-30.52K
-4.13%
Jun 30, 2025
The Vanguard Group, Inc.
388.10K
7.05%
+4.80K
+1.25%
Jun 30, 2025
Ranger Investment Management, L.P.
214.29K
3.9%
-16.70K
-7.23%
Jun 30, 2025
Geneva Capital Management LLC
199.09K
3.62%
+9.78K
+5.17%
Jun 30, 2025
Royce Investment Partners
247.61K
4.5%
-23.51K
-8.67%
Jun 30, 2025
Owens (Gary M)
136.70K
2.48%
+13.43K
+10.89%
Jun 21, 2025
Janus Henderson Investors
113.28K
2.06%
+32.54K
+40.30%
Jun 30, 2025
Atlanta Capital Management Company, L.L.C.
145.94K
2.65%
-1.85K
-1.25%
Jun 30, 2025
Ver Mais
ETFs Relacionados
Atualizado em: ter, 2 de dez
Atualizado em: ter, 2 de dez
Nome
Proporção
VictoryShares Small Cap Free Cash Flow ETF
0.22%
Principal U.S. Small-Cap ETF
0.1%
Vanguard US Quality Factor ETF
0.09%
SPDR SSGA US Small Cap Low Volatility Index ETF
0.08%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.06%
WisdomTree US SmallCap Fund
0.05%
Avantis US Small Cap Equity ETF
0.05%
WisdomTree U.S. SmallCap Dividend Fund
0.05%
Invesco Russell 2000 Dynamic Multifactor ETF
0.02%
iShares Russell 2000 Growth ETF
0.02%
Ver Mais
VictoryShares Small Cap Free Cash Flow ETF
Proporção0.22%
Principal U.S. Small-Cap ETF
Proporção0.1%
Vanguard US Quality Factor ETF
Proporção0.09%
SPDR SSGA US Small Cap Low Volatility Index ETF
Proporção0.08%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporção0.06%
WisdomTree US SmallCap Fund
Proporção0.05%
Avantis US Small Cap Equity ETF
Proporção0.05%
WisdomTree U.S. SmallCap Dividend Fund
Proporção0.05%
Invesco Russell 2000 Dynamic Multifactor ETF
Proporção0.02%
iShares Russell 2000 Growth ETF
Proporção0.02%
Dividendo
Um total de
16.82M
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Oct 03, 2025
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Dec 15, 2025 going ex on Nov 28, 2025
Nov 28, 2025
Dec 15, 2025
Nov 28, 2025
Jul 03, 2025
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Sep 15, 2025 going ex on Aug 29, 2025
Aug 29, 2025
Sep 15, 2025
Aug 29, 2025
Apr 07, 2025
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Jun 16, 2025 going ex on May 30, 2025
May 30, 2025
Jun 16, 2025
May 30, 2025
Jan 08, 2025
MLAB.NB Final Cash Dividend of gross USD 0.16 paid on Mar 17, 2025 going ex on Feb 28, 2025
Feb 28, 2025
Mar 17, 2025
Feb 28, 2025
Oct 02, 2024
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Dec 16, 2024 going ex on Nov 29, 2024
Nov 29, 2024
Dec 16, 2024
Nov 29, 2024
Jul 10, 2024
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Sep 16, 2024 going ex on Aug 30, 2024
Aug 30, 2024
Sep 16, 2024
Aug 30, 2024
Apr 05, 2024
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Jun 14, 2024 going ex on May 31, 2024
May 31, 2024
Jun 14, 2024
May 31, 2024
Jan 04, 2024
MLAB.NB Final Cash Dividend of gross USD 0.16 paid on Mar 15, 2024 going ex on Feb 28, 2024
Feb 29, 2024
Mar 15, 2024
Feb 28, 2024
Oct 03, 2023
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Dec 15, 2023 going ex on Nov 29, 2023
Nov 30, 2023
Dec 15, 2023
Nov 29, 2023
Jul 05, 2023
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Sep 15, 2023 going ex on Aug 30, 2023
Aug 31, 2023
Sep 15, 2023
Aug 30, 2023
Ver Mais
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
Perguntas frequentes
Quem são os cinco principais acionistas de Mesa Laboratories Inc?
Os cinco principais acionistas de Mesa Laboratories Inc são:
Conestoga Capital Advisors, LLC detém 566.15K Ações, representando 10.29% do total de Ações.
BlackRock Institutional Trust Company, N.A. detém 708.66K Ações, representando 12.88% do total de Ações.
The Vanguard Group, Inc. detém 388.10K Ações, representando 7.05% do total de Ações.
Ranger Investment Management, L.P. detém 214.29K Ações, representando 3.90% do total de Ações.
Geneva Capital Management LLC detém 199.09K Ações, representando 3.62% do total de Ações.
Conestoga Capital Advisors, LLC detém 566.15K Ações, representando 10.29% do total de Ações.
BlackRock Institutional Trust Company, N.A. detém 708.66K Ações, representando 12.88% do total de Ações.
The Vanguard Group, Inc. detém 388.10K Ações, representando 7.05% do total de Ações.
Ranger Investment Management, L.P. detém 214.29K Ações, representando 3.90% do total de Ações.
Geneva Capital Management LLC detém 199.09K Ações, representando 3.62% do total de Ações.
Quais são os três principais tipos de acionistas de Mesa Laboratories Inc?
Os três principais tipos de acionistas da Mesa Laboratories Inc são:
Conestoga Capital Advisors, LLC
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Conestoga Capital Advisors, LLC
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Quantas instituições possuem ações da Mesa Laboratories Inc (MLAB)?
Em 2025Q3, 387 instituições possuíam ações da Mesa Laboratories Inc, com valor de mercado aproximado de 5.12M, representando 92.75% do total de ações. Em comparação com 2025Q2, a participação institucional aumentou em -9.10%.
Qual é a maior fonte de receita da Mesa Laboratories Inc?
Em FY2026Q1, o segmento de negócios Discrete Revenues- Consumables gerou a maior receita para Mesa Laboratories Inc, totalizando 35.77M e representando 60.08% da receita total.
